Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal
Longeveron shares are trading sharply higher Tuesday afternoon following the announcement of a private placement agreement worth up to $30 million.read more...
Benzinga·6d ago
Best Biotech Stocks To Keep An Eye On - March 10th
Vertex Pharmaceuticals, BioNTech, Danaher, Longeveron, Moderna, United Therapeutics, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·6d ago
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.